391 related articles for article (PubMed ID: 27936114)
21. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
[TBL] [Abstract][Full Text] [Related]
22. κ-Carrageenan: An effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis.
Sathuvan M; Thangam R; Gajendiran M; Vivek R; Balasubramanian S; Nagaraj S; Gunasekaran P; Madhan B; Rengasamy R
Carbohydr Polym; 2017 Mar; 160():184-193. PubMed ID: 28115093
[TBL] [Abstract][Full Text] [Related]
23. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
Wei X; Senanayake TH; Bohling A; Vinogradov SV
Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
[TBL] [Abstract][Full Text] [Related]
24. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
[TBL] [Abstract][Full Text] [Related]
25. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
[TBL] [Abstract][Full Text] [Related]
26. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
Carlson LJ; Cote B; Alani AW; Rao DA
J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015
[TBL] [Abstract][Full Text] [Related]
27. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
28. Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Wanming D; Zhang D; Liu Q; Kang J
Pharmazie; 2005 Jan; 60(1):57-61. PubMed ID: 15700780
[TBL] [Abstract][Full Text] [Related]
29. Concanavaline A conjugated bacterial polyester-based PHBHHx nanoparticles loaded with curcumin for breast cancer therapy.
Kilicay E; Karahaliloglu Z; Hazer B; Tekin IÖ; Denkbas EB
J Microencapsul; 2016 May; 33(3):274-85. PubMed ID: 27049468
[TBL] [Abstract][Full Text] [Related]
30. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.
Abouzeid AH; Patel NR; Rachman IM; Senn S; Torchilin VP
J Drug Target; 2013 Dec; 21(10):994-1000. PubMed ID: 24098980
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.
Pandelidou M; Dimas K; Georgopoulos A; Hatziantoniou S; Demetzos C
J Nanosci Nanotechnol; 2011 Feb; 11(2):1259-66. PubMed ID: 21456169
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
33. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
34. Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.
Jiang H; Li ZP; Tian GX; Pan RY; Xu CM; Zhang B; Wu JL
Int J Nanomedicine; 2019; 14():1789-1804. PubMed ID: 30880980
[TBL] [Abstract][Full Text] [Related]
35. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.
Tefas LR; Sylvester B; Tomuta I; Sesarman A; Licarete E; Banciu M; Porfire A
Drug Des Devel Ther; 2017; 11():1605-1621. PubMed ID: 28579758
[TBL] [Abstract][Full Text] [Related]
36. Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy.
Saengkrit N; Saesoo S; Srinuanchai W; Phunpee S; Ruktanonchai UR
Colloids Surf B Biointerfaces; 2014 Feb; 114():349-56. PubMed ID: 24246195
[TBL] [Abstract][Full Text] [Related]
37. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
[TBL] [Abstract][Full Text] [Related]
38. Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy.
Luo CQ; Xing L; Cui PF; Qiao JB; He YJ; Chen BA; Jin L; Jiang HL
Int J Nanomedicine; 2017; 12():855-869. PubMed ID: 28182160
[TBL] [Abstract][Full Text] [Related]
39. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
[TBL] [Abstract][Full Text] [Related]
40. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
